BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22766661)

  • 21. Persistent N2 disease after neoadjuvant chemotherapy for non-small-cell lung cancer.
    Higgins KA; Chino JP; Ready N; Onaitis MW; Berry MF; D'Amico TA; Kelsey CR
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1175-9. PubMed ID: 22014344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
    Kim AW; Faber LP; Warren WH; Basu S; Wightman SC; Weber JA; Bonomi P; Liptay MJ
    Ann Thorac Surg; 2009 Sep; 88(3):937-43; discussion 944. PubMed ID: 19699924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
    Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
    Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy.
    Gudbjartsson T; Gyllstedt E; Pikwer A; Jönsson P
    Ann Thorac Surg; 2008 Aug; 86(2):376-82. PubMed ID: 18640300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
    Zhang PP; Sun JW; Wang XY; Liu XM; Li K
    Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients?
    Rivera C; Jougon J; Dahan M; Falcoz PE; Bernard A; Brouchet L
    Lung Cancer; 2012 May; 76(2):216-21. PubMed ID: 22078278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of neoadjuvant chemotherapy on complications in patients undergoing surgical treatment for non small cell lung cancer].
    Tomaszewski D; Zajac-Lenczewska I; Plichta L; Lapiński M; Murawski M; Sternau A; Skokowski J
    Pneumonol Alergol Pol; 2004; 72(11-12):477-81. PubMed ID: 16329346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
    Dediu M; Ion O; Ion R; Alexandru A; Median D; Gal C; Horvat T; Motas C; Motas N
    J BUON; 2012; 17(2):317-22. PubMed ID: 22740212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
    Daly BD; Fernando HC; Ketchedjian A; Dipetrillo TA; Kachnic LA; Morelli DM; Shemin RJ
    Ann Thorac Surg; 2006 Jul; 82(1):227-31. PubMed ID: 16798219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of preoperative radiation on survival of patients with T3N0 >7-cm non-small cell lung cancers treated with anatomic resection using the Surveillance, Epidemiology, and End Results database.
    Moreno AC; Morgensztern D; Yu JB; Boffa DJ; Decker RH; Detterbeck FC; Kim AW
    J Surg Res; 2013 Sep; 184(1):10-8. PubMed ID: 23583079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical strategy for non-small cell lung cancer in octogenarians.
    Ikeda N; Hayashi A; Iwasaki K; Kajiwara N; Uchida O; Kato H
    Respirology; 2007 Sep; 12(5):712-8. PubMed ID: 17875060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
    Ludwig C; Stoelben E; Olschewski M; Hasse J
    Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer. Impact of preoperative chemotherapy on resectability and downstaging.
    Kirn DH; Lynch TJ; Mentzer SJ; Lee TH; Strauss GM; Elias AD; Skarin AT; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):696-702. PubMed ID: 8412265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative morbidity, mortality, and survival in lung cancer associated with idiopathic pulmonary fibrosis.
    Kawasaki H; Nagai K; Yoshida J; Nishimura M; Nishiwaki Y
    J Surg Oncol; 2002 Sep; 81(1):33-7. PubMed ID: 12210025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of a limited resection for compromised or poor-risk patients with clinical stage I non-small cell carcinoma of the lung.
    Yano T; Yokoyama H; Yoshino I; Tayama K; Asoh H; Hata K; Ichinose Y
    J Am Coll Surg; 1995 Jul; 181(1):33-7. PubMed ID: 7599768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrence and survival after surgical treatment of lung cancer].
    Hjelde H; Sundstrøm S; Ødegård A; Hatlinghus S; Abusland AB; Haaverstad R
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):25-8. PubMed ID: 20094119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
    Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
    Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.